Want to see IN:ANTHEM full AI Analyst Report?

Anthem Biosciences Limited (ANTHEM) Financial Statements

5 Followers

Anthem Biosciences Limited Financial Overview

Anthem Biosciences Limited's market cap is currently ₹466.85B. The company's EPS TTM is ₹4.57; its P/E ratio is 80.86; and it has a dividend yield of 0.24%. Anthem Biosciences Limited is scheduled to report earnings on July 21, 2026, and the estimated EPS forecast is ₹3.50. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 21.24B	₹ 18.45B	₹ 14.19B	₹ 10.57B	₹ 12.31B
Gross Profit	₹ 8.95B	₹ 11.01B	₹ 8.20B	₹ 7.18B	₹ 8.22B
Operating Income	₹ 7.00B	₹ 5.92B	₹ 4.25B	₹ 3.72B	₹ 5.19B
EBITDA	₹ 8.34B	₹ 7.56B	₹ 5.68B	₹ 5.69B	₹ 6.16B
Net Income	₹ 5.92B	₹ 4.51B	₹ 3.67B	₹ 3.85B	₹ 4.06B
Balance Sheet
Cash & Short-Term Investments	₹ 9.40B	₹ 7.32B	₹ 6.43B	₹ 8.35B	₹ 6.18B
Total Assets	₹ 34.29B	₹ 28.08B	₹ 23.98B	₹ 20.14B	₹ 16.19B
Total Debt	₹ 539.24M	₹ 1.13B	₹ 2.39B	₹ 1.26B	₹ 377.95M
Net Debt	₹ -2.21B	₹ -2.03B	₹ 546.57M	₹ -2.16B	₹ -3.11B
Total Liabilities	₹ 3.87B	₹ 3.98B	₹ 4.73B	₹ 2.74B	₹ 2.64B
Stockholders' Equity	₹ 30.43B	₹ 24.10B	₹ 19.25B	₹ 17.41B	₹ 13.55B
Cash Flow
Free Cash Flow	₹ 7.06B	₹ 1.04B	₹ -1.57B	₹ 1.11B	₹ 1.72B
Operating Cash Flow	₹ 9.17B	₹ 4.18B	₹ 1.40B	₹ 3.06B	₹ 3.33B
Investing Cash Flow	₹ -7.81B	₹ -1.52B	₹ -2.21B	₹ -3.76B	₹ -2.05B
Financing Cash Flow	₹ -331.04M	₹ -1.34B	₹ -771.81M	₹ 639.74M	₹ 1.81B

Currency in INR

Anthem Biosciences Limited Earnings and Revenue History

Income Statement >

Anthem Biosciences Limited Debt to Assets

Balance Sheet >

Anthem Biosciences Limited Cash Flow

Cash Flow >

Anthem Biosciences Limited Forecast EPS vs Actual EPS

Earnings >